US Senators introduce bill to cap insulin prices

In March, the House of Representatives passed a bill that would cap patients’ insulin expenses to USD 35 a month. A new legislative proposal with the same aim has now been revealed by a bipartisan pair of senators.

Democratic Senator Jeanne Shaheen (left) and Republican Senator Susan Collins (right) | Photo: Tom Williams/AP/Ritzau Scanpix

Two US senators have revealed a new bill that would cap patients’ insulin expenses at USD 35 a month, writes industry media Endpoint News.

With the new legislative proposal, the senate is continuing the work begun by the House of Representatives, which passed a similar measure in March, the Affordable Insulin Now Act, that would also limit patient expenses to USD 35 for a month’s supply of insulin.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs